Christopher Oehlmann

Christopher Oehlmann currently serves as the Sr. Director and Head of Global Strategic Insights for Respiratory at GSK, a position held since January 2024. Prior to this role, Oehlmann was with AstraZeneca from August 2017 to January 2024, holding multiple senior positions including Sr. Director of Insights & Analytics for Global Early Assets & Business Development, where responsibilities included providing strategic partnership and market insights for the Respiratory & Immunology pipeline. Oehlmann also held roles such as Director of Global Respiratory Biologics Insights & Analytics and Forecasting Director for US Respiratory Biologics during tenure at AstraZeneca. Previous experience includes forecasting and business analysis roles at GSK, serving as Assoc. Director of Global Strategic Forecasting at Pharmacia/Pfizer, and working as a Product Manager at Decision Resources Group. Educational qualifications include a Master in International Economics and Management from SDA Bocconi and a BA in Political Economy from Tulane University.